Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2006 1
2007 1
2008 4
2009 2
2010 3
2011 3
2012 6
2013 3
2014 1
2015 2
2016 4
2017 2
2019 2
2020 3
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders.
Dvorácskó S, Herrerias A, Oliverio A, Bhattacharjee P, Pommerolle L, Liu Z, Feng D, Lee YS, Hassan SA, Godlewski G, Cinar R, Iyer MR. Dvorácskó S, et al. Among authors: lee ys. J Med Chem. 2023 Sep 14;66(17):11985-12004. doi: 10.1021/acs.jmedchem.3c00599. Epub 2023 Aug 23. J Med Chem. 2023. PMID: 37611316
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist.
Liu Z, Iyer MR, Godlewski G, Jourdan T, Liu J, Coffey NJ, Zawatsky CN, Puhl HL, Wess J, Meister J, Liow JS, Innis RB, Hassan SA, Lee YS, Kunos G, Cinar R. Liu Z, et al. Among authors: lee ys. ACS Pharmacol Transl Sci. 2021 Apr 8;4(3):1175-1187. doi: 10.1021/acsptsci.1c00048. eCollection 2021 Jun 11. ACS Pharmacol Transl Sci. 2021. PMID: 34151207 Free PMC article.
Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB1R) Receptor with Reduced Lipophilicity.
Iyer MR, Cinar R, Wood CM, Zawatsky CN, Coffey NJ, Kim KA, Liu Z, Katz A, Abdalla J, Hassan SA, Lee YS. Iyer MR, et al. Among authors: lee ys. J Med Chem. 2022 Feb 10;65(3):2374-2387. doi: 10.1021/acs.jmedchem.1c01836. Epub 2022 Jan 27. J Med Chem. 2022. PMID: 35084860
Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors.
Lindberg A, Lu S, Nag S, Schou M, Liow JS, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A, Amini N, Elmore CS, Lee YS, Innis RB, Halldin C, Pike VW. Lindberg A, et al. Among authors: lee ys. Nucl Med Biol. 2019 Mar;70:1-13. doi: 10.1016/j.nucmedbio.2019.01.005. Epub 2019 Jan 26. Nucl Med Biol. 2019. PMID: 30811975 Free PMC article.
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments.
Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, Kopajtic TA, Katz JL, Chadderdon AM, Traynor JR, Jacobson AE, Rice KC. Wang M, et al. Among authors: lee ys. Molecules. 2020 Jun 6;25(11):2640. doi: 10.3390/molecules25112640. Molecules. 2020. PMID: 32517185 Free PMC article.
Cancer: the rules of attraction.
Neckers L, Lee YS. Neckers L, et al. Among authors: lee ys. Nature. 2003 Sep 25;425(6956):357-9. doi: 10.1038/425357a. Nature. 2003. PMID: 14508471 No abstract available.
40 results